CLOSEOUT LETTER
Snyder's Lance Inc. MARCS-CMS 536150 —
- Recipient:
- Snyder's Lance Inc.
United States
- Issuing Office:
United States
|
|
|
|
60 Eighth Street N.E.
Atlanta, GA 30309 |
August 24, 2018
Ron Pepperdine
Director Regulatory Affairs
Snyder’s-Lance, Inc.
13515 Ballantyne Corporate Place
Charlotte, NC 28277
RE: Warning Letter (17-ATL-12)
Dear Mr. Pepperdine,
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter [17-ATL-12 dated October 4, 2017]. Based on our evaluation during the March 6-9, 2018 visit to your facility, it appears that you have addressed the violation(s) contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
If you have any questions regarding this letter, you may contact Janice L. King, Compliance Officer, U.S. Food and Drug Administration, 4600 Goer Drive, #106, North Charleston, SC 29406. You may also contact Ms. King at (843) 746-2990 x16 or via email at janice.king@fda.hhs.gov.
Sincerely,
/S/
Derek Price
Compliance Branch Director
U.S. Food & Drug Adminisration
FDA Atlanta District
Office of Human and Animal Foods- Division 3 East
(Georgia- North Carolina-South Carolina)